Denali Therapeutics Ownership | Who Owns Denali Therapeutics?

Denali Therapeutics Ownership Summary

Denali Therapeutics is owned by 77.58% institutional investors, 9.94% insiders, and 12.48% retail investors. Blackrock is the largest institutional shareholder, holding 8.82% of DNLI shares. Vanguard Health Care Inv is the top mutual fund, with 6.58% of its assets in Denali Therapeutics shares.

DNLI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Denali Therapeutics	77.58%	9.94%	12.48%
Sector	Healthcare Stocks	279.19%	10.62%	-189.81%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	13.17M	8.82%	$305.91M
Blackrock funding, inc. /de	13.92M	8.21%	$283.69M
Baillie gifford	12.31M	7.27%	$250.96M
Vanguard group	12.02M	7.09%	$244.99M
Wellington management group llp	9.85M	5.81%	$200.70M
Fmr	8.02M	4.73%	$163.44M
Capital research global investors	5.48M	3.23%	$111.63M
Temasek (private)	5.36M	3.16%	$109.15M
State street	4.54M	2.68%	$92.63M
Crestline management, lp	4.31M	2.54%	$87.85M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Stempoint capital lp	584.33K	2.97%	$11.91M
Crestline management, lp	4.31M	2.92%	$87.85M
Casdin capital	990.00K	1.34%	$20.18M
Camber capital management lp	2.25M	1.06%	$45.85M
Pier capital	332.32K	0.97%	$6.77M
Baker bros. advisors lp	3.73M	0.81%	$76.05M
Siren	834.03K	0.75%	$17.00M
Clarius group	410.00K	0.57%	$8.36M
Yiheng capital management	700.10K	0.55%	$14.27M
Temasek (private)	5.36M	0.43%	$109.15M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	1.07M	0.00%	1.07M
Blackrock	13.17M	0.01%	974.71K
Vanguard group	12.02M	0.00%	844.00K
Ubs group	852.86K	0.00%	711.46K
Polar asset management partners	551.09K	0.16%	509.99K

Top Sellers

Holder	Shares	% Assets	Change
Capital research global investors	5.48M	0.02%	-2.43M
Flagship pioneering	-	-	-1.36M
Gilder gagnon howe	-	-	-1.17M
Baillie gifford	12.31M	0.19%	-1.03M
Wellington management group llp	9.85M	0.04%	-879.50K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.07M	0.00%	1.07M	$21.72M
Qube research	311.51K	0.01%	311.51K	$6.35M
Segall bryant & hamill	289.07K	0.08%	289.07K	$5.89M
Twinbeech capital lp	254.59K	0.09%	254.59K	$5.19M
Mai capital management	46.53K	0.01%	46.53K	$948.20K

Sold Out

Holder	Change
Ifp advisors	-1.00
Cibc private wealth group	-1.00
Toronto dominion bank	-2.00
Bokf, na	-18.00
Cva family office	-30.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	220	-3.51%	132,840,276	3.83%	77	1.36%	108	-14.96%	80	35.59%
Dec 31, 2024	227	2.71%	127,936,943	1.24%	75	1.36%	125	8.70%	60	3.45%
Sep 30, 2024	220	6.80%	126,341,996	5.65%	74	1.49%	116	1.75%	57	-5.00%
Jun 30, 2024	204	-3.77%	119,583,732	2.39%	80	1.11%	113	2.73%	59	-13.24%
Mar 31, 2024	212	-2.75%	116,796,834	5.49%	85	1.31%	110	3.77%	68	-2.86%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	9.56M	6.58%	1.59M
Scottish Mortgage Ord	6.53M	4.50%	-
Vanguard Total Stock Mkt Idx Inv	3.78M	2.60%	17.80K
Vanguard US Total Market Shares ETF	3.33M	2.29%	-161.11K
American Funds SMALLCAP World A	3.23M	2.22%	-582.03K
Baillie Gifford US Equity Growth	3.17M	2.20%	-205.95K
iShares Russell 2000 ETF	3.18M	2.19%	1.56K
Vanguard US Growth Investor	3.03M	2.08%	-
Vanguard Small Cap Index	2.89M	1.99%	19.93K
Fidelity Growth Compy Commingled Pl S	2.06M	1.42%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 06, 2025	Ho Carole	Chief Medical Officer	Sell	$247.80K
Jan 07, 2025	Ho Carole	Chief Medical Officer	Sell	$60.49K
Jan 06, 2025	Schuth Alexander O.	COFO and Secretary	Sell	$247.80K
Jan 07, 2025	Schuth Alexander O.	COFO and Secretary	Sell	$60.49K
Jan 06, 2025	Watts Ryan J.	President and CEO	Sell	$591.76K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	8
2024 Q4	-	9
2024 Q3	-	18
2024 Q2	-	5

DNLI Ownership FAQ

Who Owns Denali Therapeutics?

Denali Therapeutics shareholders are primarily institutional investors at 77.58%, followed by 9.94% insiders and 12.48% retail investors. The average institutional ownership in Denali Therapeutics's industry, Biotech Stocks , is 63.96%, which Denali Therapeutics exceeds.

Who owns the most shares of Denali Therapeutics?

Denali Therapeutics’s largest shareholders are Blackrock (13.17M shares, 8.82%), Blackrock funding, inc. /de (13.92M shares, 8.21%), and Baillie gifford (12.31M shares, 7.27%). Together, they hold 24.30% of Denali Therapeutics’s total shares outstanding.

Does Blackrock own Denali Therapeutics?

Yes, BlackRock owns 8.82% of Denali Therapeutics, totaling 13.17M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 305.91M$. In the last quarter, BlackRock increased its holdings by 974.71K shares, a 7.99% change.

Who is Denali Therapeutics’s biggest shareholder by percentage of total assets invested?

Stempoint capital lp is Denali Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.97% of its assets in 584.33K Denali Therapeutics shares, valued at 11.91M$.

Who is the top mutual fund holder of Denali Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of Denali Therapeutics shares, with 6.58% of its total shares outstanding invested in 9.56M Denali Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools